Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

JCO Early Release, published online ahead of print Nov 16 2009
Journal of Clinical Oncology, 10.1200/JCO.2009.23.5903

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Google Scholar
Right arrow Articles by Lennon, S.
Right arrow Articles by Leyland-Jones, B.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lennon, S.
Right arrow Articles by Leyland-Jones, B.
Related Articles
Right arrowRelated Article
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Reply to S.M. Ali et al

Siân Lennon1, Claire Barton1, Ludger Banken2, Luca Gianni3, Michel Marty4, Jose Baselga5, and Brian Leyland-Jones6

1 Roche Products Ltd, Welwyn Garden City, United Kingdom
2 F. Hoffmann-La Roche Ltd, Basel, Switzerland
3 Istituto Tumori, Milan, Italy
4 Hôpital Universitaire Saint Louis, Paris, France
5 Vall d'Hebron University Hospital, Barcelona, Spain
6 Emory University, Winship Cancer Institute, Atlanta, GA


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Article

  • Value of Serum Human Epidermal Growth Factor Receptor 2 (HER2)/neu Testing for Early Prediction of Response to HER2/neu-Directed Therapies Is Still an Open One and Deserves Further Study in Large Prospective Trials
    Suhail M. Ali, Kim Leitzel, Allan Lipton, Walter P. Carney, and Wolfgang J. Köstler
    JCO 2009 27: 273 [Full Text]




About
JCO		 Editorial
Roster		 Advertising
Information		 Librarians &
Institutions		 Rights &
Permissions		 PDA Services

Copyright © 2009 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online